All In MedTech

Device Trial Radar · NCT05364606

Patient Specific Talus Spacer Post Approval Study

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Jul 8, 2022

Primary completion

Aug 30, 2033

Study completion Nov 30, 2033

Sponsor

Lead sponsor
Paragon 28Not on our public-company list
Sponsor type
Industry
First posted
May 6, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.

Conditions

  • Avascular Necrosis of the Talus

Interventions

  • Patient Specific Talus SpacerDevice

    Patient Specific Talus Spacer is a solid polished replica of the patient's bone.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinically Significant Improvement in Pain on the Visual Analog Scale (VAS)Time frame: At 5 years compared to Baseline

1 more outcomes with a free account

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Sutter Health Santa Rosa

    Santa Rosa, California · Recruiting

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.